Cystic fibrosis (CF) is characterized by both visible and concealable physical symptoms, a burdensome and time-intensive treatment regimen, and a shortened life expectancy. However, medical advances over the past six decades have led to improved quality of life (QoL) and increased life expectancy, with estimates approaching 50 years or more for those born with CF in 2000 or later [1] . As a result, CF has evolved from being viewed as a terminal childhood disease to a childhood-onset, chronic condition. However, relatively little is known about how individuals cope with the disease during adolescence or early adulthood. Thus, it is important to clarify psychological factors that may influence adaptation to CF during adolescence and early adulthood. Of particular interest in the context of adolescent development is the degree to which stigma associated with CF may have a negative influence on patient outcomes and whether a dispositional trait such as optimism may act as a buffer in the process of coping with CF.
Health-related stigma is a social process in which the experience or anticipation of negative social judgment based on a health condition results in social rejection, blame, or devaluation [2] . Conditions leading to stigma include physical deformities, showing any physical signs of illness, and belonging to a social group that results in a "spoiled identity" or undesirable reputation [3] . Additionally, factors such as the course of the condition over time and the extent to which the characteristic disrupts social interactions may influence stigma [4] . Previous research in other medical conditions has consistently found that stigma is related to increased psychological distress, worse health-related QoL, and lower self-esteem [5] [6] [7] . Although the relationship between stigma and physical health in medical populations has received little attention, psychosocial stress has been associated with poor physical health outcomes in a number of studies [8] [9] [10] . Stigma may be a particularly relevant form of psychosocial stress during adolescence and early adulthood when sense of identity is developed, greater independence from parental figures is negotiated, and social comparisons increasingly influence the establishment and maintenance of social relationships.
According to classic definitions of stigmatizing illness [3, 4] , CF may be stigmatizing due to visible symptoms (e.g., coughing, stunted or delayed growth, and taking medications with meals), a shortened life expectancy, risk for increased comorbidities and illness severity with increased age, having a genetic abnormality, and the potential for treatments and symptoms to disrupt normal functioning or activity. Qualitative data suggest that patients with CF may feel different from their peers as a result of the daily time requirements for treatments, which often occur throughout the day [11] . Consequently, patients may experience increased social anxiety in social settings [11] or choose to be noncompliant with their treatments in order to feel similar to their peers [12, 13] . Some patients with CF may choose to conceal their diagnosis from others by attempting to minimize symptoms or hide medication usage [14] . Despite the relevance of stigma in the context of CF, no quantitative studies of stigma have been conducted to date among patients with CF.
Prior studies of adult medical patients have found that the dispositional trait of optimism may buffer illness-associated stress [15] because optimism is a personality trait characterized by a general expectation of favorable outcomes [16] . Past studies suggest that greater optimism may be associated with better QoL and less distress among patients with CF. Optimism appears to be negatively correlated with psychopathology and positively correlated with QoL, but unrelated to disease severity [17] . In addition, a coping style characterized by optimistic acceptance has been associated with better QoL, especially psychosocial aspects of QoL [18] . Among children and adolescents with CF, optimism has been negatively related to internalizing symptoms (e.g., depression), independent of pulmonary function [19] . No prior study has evaluated the relationship of optimism and stigma among patients with CF.
The primary aim of this study was to evaluate the relationship of stigma to psychological and physical health in adolescents and young adults with CF (ages 14 to 25). Specifically, it was hypothesized that stigma would be related to increased symptoms of depression and anxiety, poorer CF-specific QoL, lower optimism, and worse physical health as measured by indicators of illness severity (e.g., pulmonary function, body mass index (BMI), hospitalizations during the prior six months, number of medications, and comorbid conditions). A second aim of this study was to evaluate optimism as a moderator of the relationship of stigma to psychological distress (e.g., depression, anxiety), CF-specific QoL, and illness severity (i.e., pulmonary function). It was hypothesized that stigma would be associated with lower psychological distress, better QoL, and better pulmonary function in the context of higher optimism. In the context of lower optimism, stigma was expected to be related to more psychological distress, worse QoL, and poorer pulmonary function.
Methods

Participants
Participants were recruited between July 2010 and March 2011 from a large pediatric and adult CF center in the Midwest. Male and female outpatients were eligible for participation if they were between the ages of 14 and 25, had a physician's diagnosis of CF, and had the capacity to give informed consent, or assent if under 18 years of age. Informed consent was obtained from a parent or legal guardian if the patient was under the age of 18.
Recruitment occurred by directly soliciting patients with CF during their regularly scheduled clinic visits. If interested, the patient (and parent or legal guardian if under 18) reviewed and signed the consent form, which granted access to their clinic medical records. Participants then completed a questionnaire packet during the clinic visit or online at a later time. The questionnaire packet required approximately 30 min to complete. The online format was provided as a convenience to encourage study participation and prevent the participants from feeling obligated to complete the questionnaires during the clinic visit. Follow-up calls were made, as needed, to remind participants about completing the online questionnaires. Participants received a $5 gift card for completing the assessment. This study was approved by the hospital Institutional Review Board.
Measures
Medical/health data were collected from patient medical records including BMI, hospitalizations during the prior six months, number of current medications, number of co-morbid medical diagnoses, and pulmonary function testing (PFT) results. Due to the relatively low number of hospitalizations, these data were coded as a dichotomous variable (yes or no for hospitalization in the prior six months). Comorbid diagnoses were identified by chart review and a summary score was calculated reflecting all additional medical diagnoses (excluding psychiatric diagnoses). Pulmonary function was measured with the percent predicted of forced expiratory volume in the first second (FEV 1 ), measured during PFT at the clinic visit.
Self-report questionnaires assessed demographic and background information, as well as the following measures of stigma, psychological well-being (depression, anxiety, and optimism), and CF-specific QoL:
Stigma
Perceived and enacted stigma were measured with Fife and Wright's [5] Social Impact Scale (SIS). This 24-item self-report scale was developed to assess the impact of stigma among individuals coping with chronic illnesses, and to examine the multiple dimensions of stigma. This measure is comprised of a total stigma score and four subscales representing social rejection (9 items), financial insecurity (3 items), internalized shame (5 items), and social isolation (7 items). Each item is rated on a four-point Likert scale from 1 (Strongly Disagree) to 4 (Strongly Agree) and includes a "Not applicable" response option. "Not Applicable" responses were assigned a score of 1, consistent with a "Strongly Disagree" response. Higher total scores represent more experiences or stronger perceptions of being stigmatized. Three items on the scale were modified to better fit this population; two items regarding financial insecurity were altered to incorporate both financial and academic concerns (e.g., "My job security or academic performance has been affected by my illness"); and one question from the social rejection subscale was modified to include "classmates" along with "employer/coworkers," for those participants still in school and/or too young to work. Fife and Wright [5] reported good discriminant validity, internal consistency, and construct validity for the SIS. In this sample, Cronbach's α was 0.91 for the total SIS, and α ranged from 0.63 to 0.87 for the four subscales.
Depression and anxiety
Depression and generalized anxiety were measured using the Hospital Anxiety and Depression Scale (HADS [20] ), a 14-item self-report measure. The measure includes an anxiety subscale (HADS-A), and a depression subscale (HADS-D). Each subscale is composed of seven items that are rated on a 4-point Likert scale. This is an especially useful tool among medical populations because it limits the confounding of somatic complaints by excluding somatic symptoms. The HADS has sound psychometric properties and is considered a reliable measure for detecting both anxiety and depression in medical populations [20, 21] . For each subscale, a score greater than or equal to eight indicates a clinical level of anxiety or depression [22] . In this sample, Cronbach's α was 0.83 for the total HADS scale, 0.78 for the anxiety subscale, and 0.74 for the depression subscale.
Optimism
Optimism was measured using the Life Orientation TestRevised (LOT-R [16, 23] ), a 10-item self-report measure of dispositional optimism, with several items reverse scored, four "filler" items, and responses rated 0 ("I disagree a lot") to 4 ("I agree a lot"). Higher scores indicate greater optimism and lower scores indicate greater pessimism, or the expectation that bad things will happen [23] . The LOT-R is one of the most widely used measures of optimism, with good reliability (e.g., internal and testretest) and validity (e.g., convergent, discriminant, and predictive [23] ). Internal reliability of the measure in this sample was acceptable (Cronbach's α = 0.79).
CF-related quality of life
Health-related QoL specific to CF was measured using the Cystic Fibrosis Questionnaire-Revised (CFQ-R [24] ). This measure was designed specifically for use with CF patients and has been validated with CF adolescents and adults, ages 14 and older. It consists of 50 items that are divided into 12 standardized subscales, including: physical functioning (8 items), role functioning (4 items), vitality (4 items), emotional functioning (5 items), social functioning (6 items), body image (3 items), eating disturbances (3 items), treatment burden (3 items), health perceptions (3 items), weight symptoms (1 item), respiratory symptoms (7 items), and digestion symptoms (3 items). The weight symptoms, respiratory symptoms, and digestion symptoms subscales specifically assess physical symptoms commonly experienced by patients with CF, while the other nine subscales address health-related QoL domains. Scores for each subscale range from 0 to 100 and higher scores indicate better QoL. The CFQ-R has demonstrated good reliability and validity as a health-related QoL measure for individuals with CF (age ≥ 14 [24] ). Cronbach's α ranged from 0.40 (treatment burden) to 0.92 (physical functioning) for each of the subscales, consistent with findings from a previous study [24] .
Data analysis
The primary mode of data analysis included correlational analyses, ANOVA, and hierarchical regression analyses. Correlational analyses were conducted to evaluate the relationship of stigma with psychological distress (e.g., depression and anxiety), QoL, optimism, and health outcomes (e.g., BMI, PFT, number of comorbid diagnoses, and number of medications). ANOVA was used to evaluate differences in psychological and physical variables between those with and without hospitalizations in the prior six months. Hierarchical regression analyses were used to test moderation effects of optimism in the relationship of stigma to psychological distress, QoL, and pulmonary function. For each outcome variable (i.e., psychological distress, QoL, and pulmonary function), stigma was entered in the first step, optimism was entered in the second step, and the interaction term for stigma and optimism was entered in the final step. Regression models for psychological distress and QoL were adjusted for pulmonary function, but not age or gender since neither patient-level variable was related to stigma. Analyses were conducted using Statistical Analysis Software 9.2.
Results
Of eighty-one patients who were recruited to participate in the study (n = 38 females), six patients declined (n = 2 females) due to lack of interest or time, and seventy-five agreed to participate in the study. Seventy-two participants returned completed study packets (non-completers: n = 3 male). Most participants (n = 57, 79%) completed the paper version of the questionnaire during the clinic visit. Consistent with norms for this medical population, the sample was 50% female (n = 36), 97% Caucasian (n = 70), and 3% African American (n = 2). Participants ranged in age from 14 to 25 (M = 19.1 (3.3)), and had completed an average of 11.5 (2.2) years of education. Objective indicators of health, as shown in Table 1 , include pulmonary function, total number of medications (including CF-specific medications and non-CF medications), hospitalizations, and comorbid diagnoses.
Correlational analyses of stigma with measures of physical health (i.e., BMI, PFT, number of medications, number of comorbid conditions) indicated that stigma was negatively correlated with pulmonary function, as shown in Table 2 . Lower FEV 1 % predicted was associated with greater total stigma, as well as with stigma subscales of social rejection, financial/ academic insecurity, and social isolation. Internalized shame was not associated with pulmonary function. Stigma and stigma subscales were not associated with other indicators of physical health, including hospitalizations during the prior six months.
As observed in recent population-based data from patients with CF in Germany [7] , a larger proportion of participants scored above the clinical cut-off on the anxiety subscale (n = 25, 34.7%) than the depression subscale (n = 11, 15.3%). Total stigma was positively correlated with total distress (HADS), as well as both the anxiety and depression subscales, as shown in Table 2 . Total stigma was also negatively correlated with optimism (LOT-R). The pattern of significant correlations for three of the stigma subscales (social rejection, financial/academic insecurity, social isolation) was similar to correlations for the total score. Internalized shame was the only stigma subscale not associated with depression or optimism.
Analysis of QoL data indicated that total stigma was negatively correlated with 10 of 12 CF-specific QoL subscales (physical functioning, role functioning, vitality, emotional functioning, social functioning, body image, treatment burden, health perception, weight symptoms, and respiratory symptoms). Eating disturbances and digestion symptoms were not associated with total stigma. The pattern of correlations for three of the stigma subscales (social rejection, financial/academic insecurity, social isolation) resembled that of the total score. Internalized shame was the only stigma subscale not consistently associated with the CF-specific QoL subscales.
Results of hierarchical regression analyses indicated that optimism moderated the relationship of stigma with total distress (t = − 2.63, p = 0.01), as shown in Fig. 1 . Analysis of subscales indicated that optimism moderated the relationship between stigma and anxiety (t = − 3.73, p b 0.001), but not between stigma and depression (t = − 0.39, p = 0.70). Results also indicated a significant interaction of stigma and optimism for the emotional functioning scale (t = 3.38, p = 0.001), as shown in Fig. 2 . Regression results are summarized in Table 3 . Optimism did not moderate the relationship of stigma to any of the other QoL subscales or the relationship of stigma with pulmonary function.
Discussion
This is the first study to document quantitatively a relationship between stigma and indicators of physical health, psychological functioning, and QoL in adolescents and young adults with CF. The sample reported QoL (CFQ-R) levels generally consistent with prior data from patients with mild to moderate CF, with the exception of weight symptoms and digestion symptoms, which were lower for this sample [24, 25] . Stigma (SIS) scores were similar to or lower than those reported in other medical populations [26, 27] . These data are consistent with previous research on stigma in chronically ill populations, revealing that stigma is associated with increased psychological distress, lower QoL, poorer body image, lower self-esteem, and a lower sense of personal control [5, 6] . In the current study, stigma also was related to lower levels of optimism and lower pulmonary function, but was unrelated to other objective indicators of physical health. The observed relationship between stigma and pulmonary function provides objective data consistent with the correlation of stigma with physical functioning and respiratory symptoms. Because pulmonary functioning is measured routinely during clinic visits for patients with CF, patients are regularly reminded of their pulmonary functioning status and may be more aware of this aspect of their condition than of other physical symptoms. Elevated awareness of decreased pulmonary function may contribute to a greater sense of stigmatization. Due to the cross-sectional nature of this study, the direction of the relationship between stigma and pulmonary function/symptoms cannot be determined. However, past data on stigma and physical health has utilized primarily self-reported physical symptoms rather than objective indicators of health. Thus, these data provide further concrete evidence of the relationship between physical health and psychological functioning among adolescents and young adults with CF.
Although the Internalized Shame subscale of the SIS was not associated with pulmonary function, depression, optimism, or with most of the QoL subscales, questions on this subscale Key: FEV 1 % predicted = the percent of predicted forced expiratory volume in 1 s; BMI = body mass index; SIS = Social Impact Scale; HADS = Hospital Anxiety and Depression Scale; LOT-R = Life Orientation Test-Revised; CFQ-R = Cystic Fibrosis Questionnaire-Revised.
address self-blame regarding the illness and fear of disclosure of illness to others. It appears that these aspects of stigma among patients with CF are not associated with distress or QoL possibly because the clearly genetic origin of the disease may minimize self-blame and related fears of illness disclosure.
Consistent with prior studies of other patient groups, optimism appeared to be a protective factor for emotional functioning, especially among patients experiencing higher levels of stigma. The relationship between stigma and distress (especially anxiety) was more pronounced in the context of lower optimism. Thus, Table 2 Correlation of stigma and stigma subscales with age, physical health, psychological well-being, and quality of life. 
HADS Total
Low Optimism High Optimism Fig. 1 . Distress by level of stigma and optimism. Interaction revealing that higher stigma and lower optimism were associated with elevated distress. For purposes of graphing the interaction, high levels of optimism and stigma were defined as one SD above the mean, while low levels were defined as one SD below the mean. Key: Distress = Hospital Anxiety and Depression Scale (HADS); Stigma = Social Impact Scale (SIS); Optimism = Life Orientation Test-Revised (LOT-R). higher optimism may be reflective of patients recognizing but not internalizing the stigma associated with CF. Although the CF diagnosis may be viewed as stigmatizing, greater optimism allows patients to retain a more positive outlook. Lower optimism and higher stigma may make patients especially vulnerable to experiencing symptoms of anxiety. Post-hoc analysis indicated that a contrasting model predicting stigma from the interaction of anxiety and optimism was not significant. However, due to the limited inferences that can be made from correlational data, future research should further explore the causal direction of the relationship between stigma and distress, as well as moderating variables such as dispositional optimism. Interestingly, optimism did not appear to moderate the influence of physical or social correlates of stigma (e.g., non-emotional CFQ-R subscales). Optimism may be most likely to influence emotional functioning in the context of stigma, perhaps reflecting a more direct association of optimism with emotional states than with physical states, due to a mediating role of health behavior in the relationship of optimism and physical function [28] . The regression analyses for the quality of life measure were conducted without any statistical correction because the goal of this study was to fully assess the influence of stigma on a wide range of quality of life dimensions. However, this resulted in a total of 12 regressions in the analysis of quality of life. Therefore, it is possible that the significant interaction of stigma and optimism in predicting emotional functioning occurred by chance. Key: FEV 1 % predicted = the percent of predicted forced expiratory volume in 1 s; SIS = Social Impact Scale; HADS = Hospital Anxiety and Depression Scale; LOT-R = Life Orientation Test-Revised; CFQ-R = Cystic Fibrosis Questionnaire-Revised; sr 2 = squared semi-partial correlation.
